# ROPIVACAINE HYDROCHLORIDE

NDC: 83854-014
Generic name: ROPIVACAINE HYDROCHLORIDE
Labeler / Manufacturer: Anthea Pharma Private Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, PERINEURAL
Marketing started: 20250321

FDA application: ANDA219883

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83854-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83854-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2b54355-a596-4f97-aeaa-d93e3984c42d